ITIH5, a putative tumor and metastasis suppressor gene [93], known to affect epigenetic reprogramming [94] that has been described to affect therapy response in basal-squamous-like BLCAs [95] was shown to be strongly downregulated. The gene discussed is ITIH5; the disease is neoplasm.